ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2016

Aug 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2016-08-22

Reporting Person: Myszkowski Kenneth Allen (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-22	Common Stock	M	13100	$2.01	Acquired	128789	Direct
2016-08-22	Common Stock	S	13100	$8.00	Disposed	115689	Direct
2016-08-23	Common Stock	M	6900	$2.01	Acquired	122589	Direct
2016-08-23	Common Stock	S	6900	$8.00	Disposed	115689	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-22	Stock Option (right to buy)	$2.01	M	13100	Disposed	2023-05-06	Common Stock (13100)	Direct
2016-08-23	Stock Option (right to buy)	$2.01	M	6900	Disposed	2023-05-06	Common Stock (6900)	Direct

Footnotes

F1: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.

F2: Represents first vesting date. Option vests over four years from date of grant.